Clinical Trial Update: Exploratory Study of Low Dose Psilocybin [EARLY_Phase 1]

View source ↗

Summary

An exploratory early-phase study of low-dose psilocybin for demoralization has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demoralization

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Demoralization | EARLY_Phase 1 | Status: WITHDRAWN